GSR Capital (金沙江資本), a Chinese private equity firm with backing from the Hubei provincial government, is nearing a deal to acquire control of Nissan Motor Co’s rechargeable battery unit for about US$1 billion, according to people with knowledge of the matter.
The firm is in advanced talks with Nissan about buying a stake in Automotive Energy Supply Corp (AESC), which makes the lithium-ion cells for the Japanese company’s Leaf electric car, the people said.
The parties aim to announce an agreement within the next two weeks, the people said.
The Hubei government-backed Yangtze River Industry Fund is contributing at least 20 percent of the GSR Capital fund doing the AESC deal, the people said.
GSR Capital sees value in building an independent battery supplier to multiple automakers and is considering moving some of AESC’s manufacturing to Hubei, the people said.
The central Chinese province — home to the nation’s second-largest automaker, Dongfeng Motor Group Co (東風汽車集團), and the Three Gorges Dam — has earmarked 547 billion yuan (US$79.8 billion) for investments in areas like clean energy to modernize its economy.
“This deal would bring huge benefits to both sides,” said Takeshi Miyao, an analyst at Tokyo-based market researcher Carnorama. “China is planning to manufacture batteries in the country as they encourage use of electric vehicles and AESC would be a perfect target as it has good battery technology.”
There is no certainty the talks will lead to a transaction and another buyer could still emerge.
Nissan said in an e-mailed statement it is committed to producing the best electric vehicle solutions, and continually evaluates its business strategy in pursuit of optimal products and business structure.
Global automakers have been seeking to make inroads into China, the world’s biggest electric-vehicle market. Beijing has required electric vehicle producers to choose from a list of approved battery vendors, all domestic makers, to receive subsidies.
Among the rows of vibrators, rubber torsos and leather harnesses at a Chinese sex toys exhibition in Shanghai this weekend, the beginnings of an artificial intelligence (AI)-driven shift in the industry quietly pulsed. China manufactures about 70 percent of the world’s sex toys, most of it the “hardware” on display at the fair — whether that be technicolor tentacled dildos or hyper-realistic personalized silicone dolls. Yet smart toys have been rising in popularity for some time. Many major European and US brands already offer tech-enhanced products that can enable long-distance love, monitor well-being and even bring people one step closer to
Malaysia’s leader yesterday announced plans to build a massive semiconductor design park, aiming to boost the Southeast Asian nation’s role in the global chip industry. A prominent player in the semiconductor industry for decades, Malaysia accounts for an estimated 13 percent of global back-end manufacturing, according to German tech giant Bosch. Now it wants to go beyond production and emerge as a chip design powerhouse too, Malaysian Prime Minister Anwar Ibrahim said. “I am pleased to announce the largest IC (integrated circuit) Design Park in Southeast Asia, that will house world-class anchor tenants and collaborate with global companies such as Arm [Holdings PLC],”
Sales in the retail, and food and beverage sectors last month continued to rise, increasing 0.7 percent and 13.6 percent respectively from a year earlier, setting record highs for the month of March, the Ministry of Economic Affairs said yesterday. Sales in the wholesale sector also grew last month by 4.6 annually, mainly due to the business opportunities for emerging applications related to artificial intelligence (AI) and high-performance computing technologies, the ministry said in a report. The ministry forecast that retail, and food and beverage sales this month would retain their growth momentum as the former would benefit from Tomb Sweeping Day
Thousands of parents in Singapore are furious after a Cordlife Group Ltd (康盛人生集團), a major operator of cord blood banks in Asia, irreparably damaged their children’s samples through improper handling, with some now pursuing legal action. The ongoing case, one of the worst to hit the largely untested industry, has renewed concerns over companies marketing themselves to anxious parents with mostly unproven assurances. This has implications across the region, given Cordlife’s operations in Hong Kong, Macau, Indonesia, the Philippines and India. The parents paid for years to have their infants’ cord blood stored, with the understanding that the stem cells they contained